ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication
Appropriations 2013: Obama Proposes Flat Funding for NIH
Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials
Trending Stories
- “Father of tamoxifen” V. Craig Jordan dies at 76
- NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Fred Hutch’s Christopher Li: Cancer centers should commit more resources to meet NCI’s Plan to Enhance Diversity requirements
- Most cancer centers provide paltry resources for meeting NCI’s CCSG mandate to enhance diversity, study shows